LIPOGEN LLC.

LIPOGEN LLC.

LIPOGEN LLC is a young biotech company that focuses on discovery and characterization of novel therapeutics for treatment of cancer and obesity. We believe that targeting cancer at the very root of its existence is the most successful and the least invasive treatment option. While most of the treatments are consisted of either dealing with consequences of already developed disease, Lipogen is working on both early detection, and early inhibition of cancer’s growth potential. Our team of experienced scientist and entrepreneurs are dedicated to completely characterize and commercialize novel drugs for cancer treatment. Decades of research experience and business development among the member of our team scientists will ensure that LIPOGEN LLC will successfully reach the milestones in their projects and commercialize the products. 

LIPOGEN LLC is a member of NJTC.

立博美华

LIPOGEN【立博美华】是以海外留学人员为主体创办的集新药研发和科研成果产业化为一体的高科技企业。美国LIPOGEN LLC成立于2010年,总部坐落在美国新泽西州南部伯灵顿学院内的生命科学孵化器。2012年4月,北京【立博美华】基因科技有限公司成立北京市昌平区科技园区生命园。作为一个年轻的生物医药科技公司,【立博美华】致力于治疗肥胖、糖尿病和肿瘤的新药研发工作。流行病学调查显示肥胖和二型糖尿病是肿瘤发生和发展的高危因素,随着未来可预期肥胖人数的持续增加,肿瘤等相关疾病的问题将日益严重。因应这种趋势,针对肥胖、糖尿症和肿瘤共同的病理特征即糖脂代谢(特指利用糖类合成脂类)异常,公司把研究和开发抑制肿瘤生长的脂类合成抑制剂确立为战略重点。中美【立博美华】利用各自的技术和资源优势,将在信息、技术转让和转化以及资本等领域紧密合作。美国LIPOGEN团队有着多元化的构成,包括化学合成专家、生物科学家、临床医生以及企业管理人员,科研团队综合利用多种生物模型在脂类代谢异常与疾病关系的研究中获得多项重要发现。中国公司将利用人力和资源优势以及和国内科研院所、医院等机构建立的广泛合作,将美国公司的科研成果转化推进到临床前研究。目前中美公司通过自主研发及转让方式拥有多项专利和专利开发权。